This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
A Population-Based Cohort Study of Fracture Risk Among 122,255 Adults Before and After Cancer Diagnosis Compared with Matched Controls.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival.
Breast cancer research and treatment · 2026
Measuring the Association Between the COVID-19 Pandemic and Cancer Incidence by Sex Using a Quasi-Experimental Study Design.
JCO clinical cancer informatics · 2025
Latest funding
- $439,392
Evaluating the impact of the COVID-19 pandemic on cancer control in Manitoba
CIHR · 2021 · Co-investigator
- $2,393,115
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
CIHR · 2019 · Principal investigator
- $100,000
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
CIHR · 2018 · Principal investigator
41 publications.
A Population-Based Cohort Study of Fracture Risk Among 122,255 Adults Before and After Cancer Diagnosis Compared with Matched Controls.
Ye C, Leslie WD, Al-Azazi S, Yan L, Lix LM, Czaykowski P, Singh H
The impact of the COVID-19 pandemic on breast cancer screening, treatment, and overall survival.
Decker KM, Feely A, Pitz M, Hebbard P, Kim JO, Czaykowski P, Singh H, Bucher O, Musto G, Lambert P
Measuring the Association Between the COVID-19 Pandemic and Cancer Incidence by Sex Using a Quasi-Experimental Study Design.
Decker KM, Feely A, Ratnayake I, Bucher O, Czaykowski P, Galloway K, Hebbard P, Kim JO, Musto G, Pitz M, Singh H, Lambert P
Measuring the impact of COVID-19 on time to treatment for individuals diagnosed with cancer in Manitoba, Canada using an interrupted time series analysis.
Lambert P, Galloway K, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, Pitz M, Singh H, Musto G, Decker KM
Fracture Risk Prediction Using the Fracture Risk Assessment Tool in Individuals With Cancer.
Ye C, Leslie WD, Al-Azazi S, Yan L, Lix LM, Czaykowski P, McCloskey EV, Johansson H, Harvey NC, Kanis JA, Singh H
Impact of age, comorbidity, and polypharmacy on receipt of systemic therapy in advanced cancers: A retrospective population-based study.
Rittberg R, Decker K, Lambert P, Bravo J, St John P, Turner D, Czaykowski P, Dawe DE
Measuring the impact of COVID-19 on cancer survival using an interrupted time series analysis.
Lambert P, Galloway K, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, Pitz M, Singh H, Thiessen M, Decker KM
Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
Decker KM, Musto G, Bucher O, Czaykowski P, Hebbard P, Kim JO, Singh H, Thiessen M, Feely A, Galloway K, Lambert P
New Cancer Diagnoses Before and During the COVID-19 Pandemic.
Decker KM, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, Pitz M, Singh H, Thiessen M, Lambert P
Cancer incidence during the COVID-19 pandemic by region of residence in Manitoba, Canada: A cancer registry-based interrupted time series study.
Decker KM, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, Singh H, Thiessen M, Pitz M, Musto G, Galloway K, Lambert P
Evaluating the impact of the COVID-19 pandemic on cancer control in Manitoba
Principal investigators: Decker, Kathleen M
Keywords: Cancer; Covid-19; Diagnosis; Screening; Stage; Survival; Treatment
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
Principal investigators: Zarychanski, Ryan; Christodoulou, Christodoulous; Czaykowski, Piotr; Edwards, Jeanette M; Malazdrewicz, Deborah; Mozil, Kimberley A; Rigatto, Claudio; Tessier, Angela; Wright, Brock J; Komenda, Paul V; Pitz, Marshall
Keywords: Dialysis; Implementation-Effectiveness Trial; Innovative Clinical Trials; Nephrology; Oncology; Patient-Navigation; Registry-Based Randomized Trial; Stepped-Wedge Cluster Trial; Tranexamic Acid; Transfusion Medicine
Integrating clinical data systems to improve the capacity, performance, and value of Manitoba's healthcare system
Principal investigators: Zarychanski, Ryan; Czaykowski, Piotr; Edwards, Jeanette M; Forbes, Donna M; Malazdrewicz, Deborah; Mutter, Thomas C; Pitz, Marshall; Sareen, Jitender; Singer, Alexander G; Tessier, Angela; Bolton, James M; Katz, Alan; Klassen, Terry P; Lavoie, Josée G; Lix, Lisa M
Keywords: Big Data; Cancer Journey; Comparative Effectiveness Research; Indigenous Health; Innovative Clinical Trials; Mental Health; Patient Safety; Pragmatic Clinical Trials; Primary Care; Under Serviced Populations
The impact of age on patterns of treatment among adult cancer patients in Manitoba
Principal investigators: Dawe, David
Keywords: Cancer Treatment Disparities; Epidemiology; Geriatric Oncology; Health Services Research
An Urgent Cancer Care Clinic: evaluating the benefits and costs of a specialized model of delivery of health care for cancer patients
Principal investigators: Decker, Kathleen M; Czaykowski, Piotr
Keywords: Access To Care; Benefits; Cancer; Costs; Health Services Research; Urgent Care
A population-based prospective intervention to evaluate the effectiveness of cancer patient navigation
Principal investigators: Decker, Kathleen M; Pitz, Marshall; Singh, Harminder
Keywords: Cancer; Clincial Outcomes; Cost-Effectiveness; Effectiveness; Navigation; Patient-Reported Outcomes
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Oncology
- Internal Medicine
- Community Health Sciences
- Biostatistics Division
- Biology
- Clinical Pharmacology
- Medicine
- Other
Co-authors at University of Manitoba, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Harminder Singh
Biology
15 shared papers, latest 2026
Harminder Singh
Community Health Sciences
15 shared papers, latest 2026
Marshall Pitz
Internal Medicine
8 shared papers, latest 2026
Eric Winquist
Clinical Pharmacology
7 shared papers, latest 2022
Sebastien Hotte
Oncology
6 shared papers, latest 2022
Christina Canil
Faculty
5 shared papers, latest 2022
Carrie Ye
Medicine
3 shared papers, latest 2026
Kathleen Decker
Community Health Sciences
3 shared papers, latest 2024
Aly-Khan Lalani
Oncology
3 shared papers, latest 2020
Nicholas Power
Department of Surgery
2 shared papers, latest 2022
Lucia Nappi
Urologic Sciences
2 shared papers, latest 2022
Alan Katz
Community Health Sciences
2 shared papers, latest 2021
Som Mukherjee
Oncology
2 shared papers, latest 2020
Michael Kolinsky
Oncology
1 shared papers, latest 2019
Arjun Sahgal
Faculty
1 shared papers, latest 2021
Scott Tyldesley
Faculty
1 shared papers, latest 2022
Wassim Kassouf
Surgery
1 shared papers, latest 2019
Libni Eapen
Radiology
1 shared papers, latest 2019
Sareh Keshavarzi
Biostatistics Division
1 shared papers, latest 2021
Lisa Wang
Biostatistics Division
1 shared papers, latest 2019
Philip St.John
Internal Medicine
1 shared papers, latest 2024
Daniel Chateau
Community Health Sciences
1 shared papers, latest 2012
Eric Levesque
Hematology-Oncology
1 shared papers, latest 2016
Philippe Violette
Surgery
1 shared papers, latest 2019
Ryan Zarychanski
Internal Medicine
1 shared papers, latest 2019
Anand Swaminath
Oncology
1 shared papers, latest 2021
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.